| James Edward Slattery, MD | |
|
2810 N Swan Rd, Suite 100, Tucson, AZ 85712-6305 | |
| (520) 324-2030 | |
| Not Available |
| Full Name | James Edward Slattery |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 20 Years |
| Location | 2810 N Swan Rd, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023200607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 38188 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lutheran Medical Center | Wheat ridge, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prime Anesthesia Pllc | 5799106019 | 13 |
| Physician Anesthesia Services Pc | 7517947146 | 39 |
News Archive
BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that a study published in the Proceedings of the National Academy of Sciences demonstrated that hyperthermia can be a powerful tool to inhibit the ability of cancer cells to repair the DNA damage caused by radiation or chemotherapy.
BETHESDA, Md.,GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial at the Annual Meeting of the Society of Urologic Oncology.
University of Utah biochemists have reported a new drug discovery tool against the Ebola virus. According to a study published in this week's online edition of Protein Science, they have produced a molecule, known as a peptide mimic, that displays a functionally critical region of the virus that is universally conserved in all known species of Ebola.
On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon announced his plans to lift a Mexican Ministry of Economy requirement that pharmaceutical companies operating in Mexico must have a manufacturing plant in that country in order to use or sell generic versions of their lifesaving AIDS and other drugs in Mexico.
The U.S. Food and Drug Administration today approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body (metastatic).
› Verified 9 days ago
| Entity Name | Physician Anesthesia Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861476590 PECOS PAC ID: 7517947146 Enrollment ID: O20040723000048 |
News Archive
BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that a study published in the Proceedings of the National Academy of Sciences demonstrated that hyperthermia can be a powerful tool to inhibit the ability of cancer cells to repair the DNA damage caused by radiation or chemotherapy.
BETHESDA, Md.,GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial at the Annual Meeting of the Society of Urologic Oncology.
University of Utah biochemists have reported a new drug discovery tool against the Ebola virus. According to a study published in this week's online edition of Protein Science, they have produced a molecule, known as a peptide mimic, that displays a functionally critical region of the virus that is universally conserved in all known species of Ebola.
On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon announced his plans to lift a Mexican Ministry of Economy requirement that pharmaceutical companies operating in Mexico must have a manufacturing plant in that country in order to use or sell generic versions of their lifesaving AIDS and other drugs in Mexico.
The U.S. Food and Drug Administration today approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body (metastatic).
› Verified 9 days ago
| Entity Name | Prime Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427685247 PECOS PAC ID: 5799106019 Enrollment ID: O20200521003204 |
News Archive
BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that a study published in the Proceedings of the National Academy of Sciences demonstrated that hyperthermia can be a powerful tool to inhibit the ability of cancer cells to repair the DNA damage caused by radiation or chemotherapy.
BETHESDA, Md.,GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial at the Annual Meeting of the Society of Urologic Oncology.
University of Utah biochemists have reported a new drug discovery tool against the Ebola virus. According to a study published in this week's online edition of Protein Science, they have produced a molecule, known as a peptide mimic, that displays a functionally critical region of the virus that is universally conserved in all known species of Ebola.
On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon announced his plans to lift a Mexican Ministry of Economy requirement that pharmaceutical companies operating in Mexico must have a manufacturing plant in that country in order to use or sell generic versions of their lifesaving AIDS and other drugs in Mexico.
The U.S. Food and Drug Administration today approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body (metastatic).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Edward Slattery, MD 2810 N Swan Rd, Suite 100, Tucson, AZ 85712-6305 Ph: (520) 324-2030 | James Edward Slattery, MD 2810 N Swan Rd, Suite 100, Tucson, AZ 85712-6305 Ph: (520) 324-2030 |
News Archive
BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that a study published in the Proceedings of the National Academy of Sciences demonstrated that hyperthermia can be a powerful tool to inhibit the ability of cancer cells to repair the DNA damage caused by radiation or chemotherapy.
BETHESDA, Md.,GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial at the Annual Meeting of the Society of Urologic Oncology.
University of Utah biochemists have reported a new drug discovery tool against the Ebola virus. According to a study published in this week's online edition of Protein Science, they have produced a molecule, known as a peptide mimic, that displays a functionally critical region of the virus that is universally conserved in all known species of Ebola.
On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon announced his plans to lift a Mexican Ministry of Economy requirement that pharmaceutical companies operating in Mexico must have a manufacturing plant in that country in order to use or sell generic versions of their lifesaving AIDS and other drugs in Mexico.
The U.S. Food and Drug Administration today approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body (metastatic).
› Verified 9 days ago
Holly Jeanne Graham, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Grant Rd, Thmep, Tucson, AZ 85712 Phone: 520-324-5095 | |
Dr. Ryan William Matika, MD Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: Department Of Anesthesiology, 1501 N. Campbell Avenue, Tucson, AZ 85724 Phone: 520-626-7221 | |
Kevin Evans, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2810 N Swan Rd Ste 100, Tucson, AZ 85712 Phone: 520-324-2030 Fax: 520-445-6019 | |
Dr. Rhesa Screven Farmer Iii, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3390 N Campbell Ave, Ste 110, Tucson, AZ 85719 Phone: 520-795-7650 Fax: 520-325-1622 | |
Stuart Hameroff, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Campbell Ave, Tucson, AZ 85724 Phone: 520-694-8888 Fax: 520-626-6066 | |
Dr. David Bruce Longenecker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3390 N Campbell Ave, Suite 110, Tucson, AZ 85719 Phone: 520-795-7650 | |
Dr. Murray Manson, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6213 N Pascola Circle, Tucson, AZ 85718 Phone: 520-529-1830 Fax: 520-529-7314 |